1. Pink Sheet

US FDA ‘State Of Quality’ Report Targets Unreviewed, Uninspected Risks

 
• By Bowman Cox

The poorest-quality pharmaceuticals consumed in the US are the ones FDA has never reviewed, or are from sites the agency has never inspected, regardless of country of origin; the agency’s inaugural ‘State of Quality’ report contains some surprising findings.  

Dark and eerie industrial urban city street at night in Chicago - Image
Uninspected facilities making unreviewed drugs have poorest quality, FDA finds.

In its first annual report on the state of pharmaceutical quality, the US Food and Drug Administration highlighted several trouble areas – sites that make drugs the agency has not reviewed, that operate facilities it has not yet inspected, or that were involved in recalls.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance